Terumo (OTCMKTS:TRUMY) Stock Price Up 5.1% – Should You Buy?

Shares of Terumo Corp. (OTCMKTS:TRUMY) rose 5.1% during trading on Friday . The stock traded as high as $12.93 and last traded at $12.80. Approximately 89,837 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 377,455 shares. The stock had previously closed at $12.18.

Analyst Upgrades and Downgrades

TRUMY has been the topic of several recent analyst reports. Zacks Research upgraded shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Nomura upgraded shares of Terumo to a “hold” rating in a report on Tuesday, February 24th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Terumo Stock Performance

The company has a market capitalization of $18.82 billion, a price-to-earnings ratio of 22.00 and a beta of 0.62. The company has a current ratio of 1.51, a quick ratio of 0.89 and a debt-to-equity ratio of 0.07. The stock’s fifty day simple moving average is $13.08 and its 200-day simple moving average is $14.01.

Terumo (OTCMKTS:TRUMY) last released its earnings results on Friday, May 15th. The company reported $0.11 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.11. Terumo had a net margin of 11.74% and a return on equity of 9.01%. Analysts predict that Terumo Corp. will post 0.58 EPS for the current year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.